T Central Memory Cells in Early Localized Non-Segmental Vitiligo
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Assessing the level of circulating TCMs (CD8+ CD3+ CCR7+ CD45RO+ cells) in early localized
vitiligo cases prior to treatment and after treatment in comparison to healthy controls.
This, in turn, would provide insights regarding the role of TCMs in vitiligo and the role of
early treatment in halting disease progression and autoimmune memory formation that accounts
for high recurrence rate of vitiligo